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1. Introduction
Successful microorganisms are those that can evade the immune responses of the host. To reach
this purpose, many pathogens have evolved as intracellular organisms, acquiring the capacity
to live and to develop inside cells. This cellular parasitism has many benefits for pathogens
such as protection from circulating antibodies, free access to nutrients and to specialized
compartments that microorganisms use to establish their replicative niches. According to their
particular lifestyles and requirements, many pathogens such as L.monocytogenes, Shigella or T.
cruzi; reproduce in cell cytosol, while others target specific vesicles to generate particular
compartments called parasitophorous vacuoles (PVs). This class of parasitism is utilized by
M. tuberculosis, C. burnetii or T. gondii. On the other hand, in response to this level of adaptation,
mammalian cells have developed different processes for eliminating intracellular microor‐
ganisms or for keeping them under strict control. These mechanisms are part of the innate
immune responses, being phagocytosis (and the related processes) the best characterized.
Innate cellular immunity also encompasses the autophagic process, a well conserved eukary‐
otic pathway that interacts with intracellular pathogens under certain circumstances to
produce the destruction of the foreign organism. Autophagy comprises the inclusion of
pathogens in autophagic-derived compartments and delivers them in lysosomes for digestion.
Some pathogens, however, have acquired the capacity to subvert autophagy for their own
benefit. This chapter will describe the interaction between intracellular microorganisms and
the defense mechanisms of host cells, with special focus on the dual involvement of autophagy
against pathogens, and the net outcome of this interaction.
© 2013 Romano; licensee InTech. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
2. The phagocytosis process
Phagocytosis is a form of endocytosis mainly present in specialized types of cells: the profes‐
sional phagocytes that include the neutrophil, monocytes/macrophages, and dendritic cells.
In the initial stage of phagocytosis, the cells change shape by sending out membrane projec‐
tions (pseudopodia) that contact and surround the particle (bacteria, apoptotic bodies, etc) in
a receptor-mediated and actin-dependent process (Figure 1). When the tips of the pseudopodia
meet each other, membrane fusion occurs and the particle is enveloped in a vesicular com‐
partment called phagosome. According to the type of internalized particle and the class of
phagocyte involved, a different set of processes are activated that end in the destruction of the
enclosed material. These mechanisms involve:
2.1. The respiratory or oxidative burst
The respiratory or oxidative burst is produced by the activity of specialized enzymes such as
NADPH oxidase, which generates superoxide that recombines with other molecules as NO to
form peroxynitrite, a potent oxidant agent against bacteria and parasites. Neutrophils and
monocytes also utilize myeloperoxidase to further combine H2O2 with Cl- to produce hypo‐
chlorite, a harmful component of phagosomes [1]
2.2. The production of microbicidal substances
Lysozime and defensins attack cell walls and membranes of certain bacteria.
2.3. Phagosome maturation
Phagosome maturation is a process that confers to nascent phagosomes the ability to kill
pathogens or to degrade the ingested materials. Phagosomal maturation involves a complex
sequence of reactions that result in the drastic remodeling of the phagosomal membrane and
contents, produced as a consequence of vesicular fusion and fission events between the nascent
vacuole and other cellular compartments mainly belonging to the endocytic pathway [2]. Rab
and SNARES proteins are the main molecular components that regulate these events. Rabs are
small GTP-binding proteins that control intracellular trafficking and supervise the mainte‐
nance of specific organellar identity, whereas SNARES are transmembrane proteins that,
associating with their specific partners, form complexes that are the final executioners of the
fusion processes between membranes. Interactions between phagosomes and endosomes
commence soon after phagosome sealing, in a fashion that recapitulates the endocytic
sequence: nascent (early) phagosomes (Eph) seemingly fuse initially with sorting (early)
endosomes (EE), followed by late endosomes (LE) and ultimately lysosomes (Ly). Therefore,
the membrane of Eph initially acquires components present in early endosomes such as Rab
5, phosphatidylinositol 3-phosphate (PI3P), Early Endosomal Antigen 1 (EEA-1) and Vamp-3.
In contrast, late phagosomes (Lph) present Rab 7, Mannose-6-phosphate receptor, Vamp-7 and
Lysosomal associated membrane proteins 1 and 2 (LAMPS 1 and 2) [2]. Furthermore, the
luminal environment of phagosomes turned progressively more acidic due to the accumula‐
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tion of H+ ATPase complexes in the phagosome membrane [3]. Phagolysosomes (PLy), the
hybrid compartment generated by fusion between Lph and lysosomes, reach a pH of around
4.5, favoring the maturation of acidic hydrolases that will finally digest the materials (Figure
1, red compartments). Lysosomes contain several proteases, including Cathepsin D and
Elastase, which are essential for killing various bacteria.
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Figure 1. Phagocytosis and autophagy are the main cellular processes involved in the innate immune respons‐
es against pathogens. The scheme depicts the vesicular compartments that belong to each process and the main
molecules that characterize them. Note that earlier, non-degradative compartments are colored in blue whereas acid‐
ic, lysosomal derived compartments are showed in red.
All these mechanisms generate a high level of protection against a wide range of patho‐
gens.  Paradoxically,  phagocytosis  can  also  have  deleterious  effects  for  the  host:  certain
pathogens, exemplified by Mycobacteria, take advantage of the phagocytic machinery to gain
access to the cell interior where, by subverting the maturation process, become intracellu‐
lar pathogens [4–6].
Phagocytosis can also be produced in a class of cells different from immune cells. These “non
-professional phagocytes” are cells with low phagocytic competence. Pathogens that can
colonize these cells avoid the harmful ambient of the phagocyte-derived phagosome because
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many of the killing processes described for phagocytes are low or absent in non-professional
phagocytes, keeping lysosomal degradation as the main defense system. In this way, the
autophagic pathway which delivers cytoplasmic materials to lysosomes constitutes an
important mechanism for eliminating pathogens, especially in these non-immune cells.
3. The autophagic pathway
Autophagy is a catabolic process that involves the degradation of cell components through
the  lysosomal  machinery.  Macroautophagy,  the  most  studied  type  of  autophagy,  is
important  in  many  physiological  situations  such  as  development,  cell  growth,  and  cell
differentiation. As a constitutive process, autophagy functions at basal levels in the turnover
of long lived proteins and old organelles for maintaining cellular homeostasis. It can also
be stimulated under different stress situations such as nutrient starvation, oxidative stress
and intracellular infections [7].
The autophagic process involves specific compartments inside the cell. The initial preauto‐
phagosomal structures (PAS) are recruited to the cellular sites where autophagy is initiated [8].
A large number of studies have shown that specialized regions of the endoplasmic reticulum
(ER) are involved in the formation of PAS [9,10]. However, more recent data indicate that
besides ER other compartments like mitochondria, Golgi complex (GC) or plasma membrane
(PM) may participate in this process [11–13]. The phagophorus, or isolation membrane,
generated by fusion of PAS, is a curved membrane that in a way similar to that of the pseu‐
dopodia of macrophages, wraps the materials to be trapped which, in this case, consist of
soluble or membranous content from cytoplasm (Figure 1, left). This membrane finally closes
in a structure called autophagosome that transports the cargo for degradation. Immature
(early) autophagosomes (EAP) are double-membrane vesicles easily recognized by electron
microscopy [14]. Autophagosomes fuse with endocytic compartments (LE or multivesicular
bodies, MVB) to form amphisomes (AP) that, in turn, fuse with lysosomes; forming autopha‐
golysosomes (APL) where the materials are degraded (Figure 1, red compartments).
At  the  molecular  level,  a  large  number  of  proteins  engage  in  autophagy.  The  specific
autophagy related proteins (Atgs) are a large family of proteins that regulate the nuclea‐
tion of PAS, and the formation and elongation of phagophorus and autophagosomes. At
least 16 genes were found to be important for autophagy in yeasts, especially in the PAS
nucleation [15]. Two protein conjugation reactions, both catalyzed by the action of Atg7,
(an E3-like ubiquitin ligase activity), are mainly required for autophagosome formation in
mammals.  The  mammalian  Atg5-Atg12-Atg16L  complex  is  recruited  to  the  isolation
membranes, favoring the elongation of the precursor membrane. The second conjugation
system yields LC3-II which inserts into the autophagosomal membrane and contributes to
vesicle elongation [16]. Pro-LC3 is initially cleaved by Atg4 to produce LC3-I. This molecule
is  a  soluble  protein  distributed  in  the  cytoplasm.  After  autophagic  induction,  LC3-I  is
conjugated with phosphatidylethanolamine (PE), allowing the insertion in the membrane
of autophagic vesicles [16]. Two key signaling nodes converge to correlate autophagy with
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cell nutrient or stress conditions. The Tor-Atg1 signaling cascade transduces the response
from  growth  factors,  via  class  I  PI3K,  Akt/PKB,  and  so  forth,  to  negatively  regulate
autophagy [17]. The second system, formed by Beclin1 (Atg6) and hVps34, is a lipid kinase
that  produces  PI3P,  which plays  a  pivotal  role  in  early  autophagosome formation,  LC3
lipidation and the maturation of autophagosomes into autolysosomes [18].
Proteins that regulate transport and fusion events between vesicles are also important in
autophagosome formation and maturation. Rab 7, a protein involved in transport to late
endosomes and in the biogenesis of the perinuclear lysosome compartment is required for the
normal progression of autophagosomes to autophagolysosomes [19]. The N-ethylmaleimide-
sensitive factor attachment protein receptors (SNARES) Vamp3 and Vamp7 are important
during the first steps of autophagy [20,21], whereas Vamp7 and Vamp8 also participate in the
autophagosome-lysosome fusion [20,22]. Furthermore, it has been recently shown that actin
has a role in the very early stages of autophagosome formation, linked to the PI3P generation
step [23]. The description above shows that autophagosome formation and maturation engage
similar molecular transport components and fusion machinery than that required for pro‐
gression in endocytic and phagocytic pathways (Figure 1).
The process of autophagy can be monitored intracellularly by utilizing LC3 fused to a
fluorescent protein (GFP-LC3 or mCherry-LC3). As the fluorescent LC3 is incorporated into
autophagosomes, they can be seen as small puncta within the cell. As autophagy is a highly
dynamic process, the number of puncta seen in a cell is a function of initiation as well as
clearance (lysosomal fusion and subsequent degradation) [24]. Autophagosome initiation can
be inhibited by blocking Class III PI3 kinases (Vps34) with 3-methyladenine or wortmannin,
or by knockdown of essential factors such as Atg5 or Beclin-1, a component of Vps34 kinase
complex. Autophagosome clearance can be prevented by interfering with lysosomal fusion by
Bafilomycin A1, chloroquine, and other agents that tend to alkalinize the lysosome (e.g.
NH4Cl). Rapamycin inhibits the TOR signaling pathway, leading to induction of autophagy.
Spermidine and resveratrol have been recently characterized as autophagy inducers. Genetic
and functional studies indicate that spermidine inhibits histone acetylases, while resveratrol
activates the histone deacetylase Sirtuin 1. Although it remains elusive whether the same
histones (or perhaps other nuclear or cytoplasmic proteins) act as the downstream targets of
spermidine and resveratrol, these results point to an essential role of protein hypoacetylation
in autophagy control [25]. This hipoacetylated protein status leads to upregulation of several
atg genes, including atg7, atg11 and atg15 in several organisms such as mammals, yeasts,
nematodes and flies [26].
As explained above, host autophagy is a component of the innate responses against intracel‐
lular pathogens that generally functions as a second barrier when phagocytic or other defense
mechanisms are exceeded. However, some pathogens have the capacity to evade autophagic
responses or to subvert the autophagic pathway and to live and replicate inside autophago‐
somal compartments. The following sections describe the opposite effects of autophagic
response against microorganisms.
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3.1. Autophagy as a component of the innate immune responses
In order to internalize host cells, many pathogens induce their own ingestion in phagocytic
cells. After entry, pathogenic microorganisms manipulate the normal (or “canonical”)
phagocytic pathway to evade lysosomal degradation and to achieve the maximal benefits
(protection, nutrition, survival, and replication) from cells. These actions include inhibition of
phagosome maturation, escape from phagosome to cytoplasm and development in a vacuole
with particular characteristics. As a component of immune responses, autophagy hampers
these mechanisms enclosing viruses, bacteria or parasites in compartments which share
characteristics and molecular machinery with canonical autophagosomes, a process usually
named as xenophagy [27]. For a better comprehension of the autophagic action, each patho‐
genic strategy will be described, and the most characteristic pathogen of each group will be
exemplified in the following paragraphs.
• The Mycobacteria case: A marquee feature of the powerful human pathogen Mycobacterium
tuberculosis is its macrophage parasitism. The intracellular survival of this microorganism
rests upon its ability to arrest phagolysosome biogenesis, avoid direct cidal mechanisms in
macrophages, and block efficient antigen processing and presentation. Lipoarabinomannan
(LAM) and phoshatidylinositol mannoside (PIM) are two toxins elaborated by Mycobacte‐
rium tuberculosis that stimulate fusion between phagosomes and early endosomes and
prevent Rab conversion on phagosomes by interference with Rab effectors, especially the
type III PI3K (hVps34). LAM abolishes the normal recruitment of PI3K to mycobacterium
phagosomal membrane decreasing the levels of PI3P. The final result is the reduction of the
recruitment of EEA-1 and other effectors and the inhibition of the normal progression from
early to late phagosomes [28]. Thus, a critical feature of the M. tuberculosis phagosome is its
lack of the vacuolar H+ ATPase [29] and mature lysosomal hydrolases, such as Cathepsin
D. In stark contrast, the induction of autophagy by physiological, pharmacological or
immunological signals, including the major antituberculosis Th1 cytokine IFN-gamma, can
overcome mycobacterial phagosome maturation block. Almost ten years ago, Gutierrez and
colleagues demonstrated that when infected macrophages were treated in conditions that
induce autophagy, mycobacterium-containing phagosomes become more acidic and also
acquire markers of maturation, including the vacuolar H+ ATPase, LAMP-1, LBPA and
Cathepsin D. Additionally, starvation promotes recruitment to mycobacterial phagosomes
of critical autophagy components such as LC3, indicating that these phagosomes are
redirected to a compartment with autophagic characteristics that finally fuses with lyso‐
somes [30]. The most remarkable finding of this work was the demonstration that autophagy
induction hampered the survival of this intracellular pathogen, recognizing to autophagy
as an effector of innate immunity (see Figure 2A).
• The group A Streptococcus case: The second case belongs to pathogens that escape from
phagosomes and turn into cytosolic invaders. The Group A of Streptococcus (GAS) is often
internalized into nonphagocytic epithelial cells via the endocytic pathway. At early times
after infection, GAS secrets its major virulence factor: the cytolysin streptolysin O (SLO) that
supports the escape of GAS into the cytoplasm from endosomes [31]. After escaping, GAS
became enveloped by autophagosome-like compartments and were killed upon fusion of
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these compartments with lysosomes. In contrast, in autophagy-deficient Atg5-/- cells, GAS
survived, multiplied, and were released from the cells [32,33]. Additionally a SLO-deficient
mutant of GAS was viable for a longer time than the wild-type strain, although it failed to
escape the endosomes [31]. Both results highlight the crucial role of autophagy in the
suppression of intracellular survival of this pathogen. A similar conclusion was recently
obtained with Staphylococcus aureus. After invasion of non-phagocytic cells, virulent strains
of this gram positive bacterium stimulate autophagy and become entrapped in intracellular
PI3P-enriched vesicles and its effector WIPI-1, a protein present in the membrane of both
phagophores and autophagosomes. This interaction seems to be deleterious for bacteria,
given that these autophagosome-like WIPI-1 positive vesicles that envelope S. aureus are
finally targeted for lysosomal degradation [34].
• The Toxoplasma case: The third strategy used by pathogenic organisms is to create a special‐
ized compartment that remains isolated from the host endocytic or phagocytic networks.
Toxoplasma gondii relies on this mechanism; the membrane of its PV is nonfusogenic due to
its unique composition lacking host proteins. Nonetheless, macrophages infected with
Toxoplasma can reroute the pathogen-containing compartment to lysosomes. Autophagy
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Figure 2. Mechanisms of pathogen-host autophagy interactions. As a component of innate immune responses
against intracellular pathogens, autophagy can effectively eliminate some pathogens, re-routing them to lysosomes
(autophagolysosomes). That is the case of Mycobacterium tuberculosis (A). In contrast, some microorganisms such as
Coxiella burnetii utilize autophagic compartments to delay lysosomal fusion until differentiating into more resistant
forms (B). On the other hand, Trypanosoma cruzi exploits the autophagic pathway to efficiently colonize host cells (C).
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plays a key role in this process [35,36]. When CD40 of human or mouse macrophages
infected with T. gondii is stimulated with (CD154+) CD4+ T cells or exposed to anti-CD4
antibodies, the nonfusogenic nature of the PV is reversed and the vacuole fuses with late
endosomes and lysosomes. This fusion is dependent on autophagy, as indicated by the
inhibition of this mechanism in cells knockdown for Beclin 1 or treated with 3-MA, an
inhibitor of phagophore formation. CD40 activation also stimulates expression of LC3 that
localizes to the PV [36].
3.2. Evasion of autophagic responses
Despite the potent effect of autophagy in killing intracellular pathogens, some microbial
pathogens have the capacity to control cellular autophagy and successfully parasitize eukary‐
otic cells. These highly evolved microorganisms have developed specific virulence factors to
protect themselves from autophagic elimination by producing:
• Prevention of autophagy induction: Several viruses direct their products to essential autophagic
proteins, causing them to be functionally inhibited. The herpes virus family can produce
autophagy blockage through different mechanisms. The HSV-1 ICP34.5 viral protein
encoded by herpes simplex virus type 1 blocks Beclin1 function and confers neurovirulence
in mice [37]. A similar mechanism was recently shown for human cytomegalovirus; the virus
protein TRS1 interacts with Beclin 1 to inhibit autophagy [38]. Gamma-herpesviruses,
including important human pathogens such as Epstein Barr virus or Kaposi's sarcoma-
associated HIV, displayed a different type of inhibition. They encode homologs of the
antiapoptotic, host Bcl-2 protein to promote viral replication and pathogenesis. Cellular
Bcl-2 and their viral homologs have the property to bind and inhibit Beclin1, suppressing
both apoptotic and autophagic responses [39]. It is not yet clear whether other intracellular
pathogens besides viruses also actively suppress initiation of the autophagy pathway. In
contrast, many bacteria display the following actions.
• Suppression of autophagosome maturation into autolysosome: Similar to mycobacterium phago‐
some maturation arrest, other pathogens have the ability to suppress autophagosome
maturation. They specifically reside in vacuoles with autophagosomal characteristics in
order to survive and replicate, but avoid transient or permanent fusion with lysosomes.
Porphyromonas gingivalis, a bacterial periodontal pathogen that can localize to atherosclerotic
plaques, traffics to autophagosomes as a way of evading the conventional endocytic
trafficking to lysosomes [40], After intracellular uptake, P. gingivalis transits from early
autophagosomes to late autophagosomes and prevents the formation of autolysosomes, a
mechanism not yet well elucidated [41]. On the other hand, a delay in the delivery of
lysosomal enzymes to phagosomes was initially described for dimorphic bacteria and
named “the pregnant pause”. The dimorphic life cycles of these pathogens have dramatic
consequences for phagosome traffic. In the transmissible state, C. burnetii, L. pneumophila
and others, such as Leishmania sp., block phagosome maturation; after a pregnant pause that
includes the bacterial differentiation process, replicative forms emerge and thrive in
lysosomes [42]. Autophagy is one of the mechanisms activated by these intracellular
pathogens for delaying lysosomal fusion. At late stages of cellular infection, both Coxiella
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burnetii and Legionella pneumophila develop vacuoles that have characteristics of phagoly‐
sosomes and are also decorated with LC3 [43,44]. In the case of C. burnetii, acquisition of
LC3 is even an early event in the transit of phagosomes containing bacterium (Cph) and
depends on bacterial protein synthesis because chloramphenicol avoid this LC3 recruitment
[45]. Interactions with autophagic and also late endocytic compartments are maintained
during the transit of Cph and in the development of the Coxiella replicative vacuoles (CRV)
[46]. Indeed, autophagy induction or the overexpression of autophagic proteins LC3 and
Rab 24 favor the generation and maturation of this CRV [47]. Taking together, these results
demonstrated that C. burnetii transits through the normal endo/phagocytic pathway but
actively interacts with autophagosomes at early times after infection. This intersection
delays fusion with the lysosomal compartment, possibly favoring the intracellular differ‐
entiation and survival of the bacteria. In this period, C. burnetii differentiates from the
transmissible forms (named small cell variant) to the replicative forms (large cell variant)
(Figure 2B). In the case of L. pneumophila, it was recently demonstrated that this bacterium
produced several Type IV effector proteins that control the timing of bacteria during
intracellular transport. The early secretion of DrrA/SidM, LidA, and RalF factors, prolong
association with the ER and permit the persistence of the bacteria in immature autophago‐
somal vacuoles for a period sufficient to differentiate into an acid-resistant, replicative form.
Subsequent secretion of LepB releases the block of autophagosome maturation, and the
adapted progeny continue to replicate within autophagolysosomes [48].
• Evasion of pathogen recognition by the autophagic machinery: This strategy is especially impor‐
tant in intracytoplasmic pathogens such as Shigella flexneri, L. monocytogenes, and Burkhol‐
deria pseudomallei. Shigella VirG, a protein required for intracellular actin-based motility,
induced autophagy and favored the microorganism trap by autophagosomes, after binding
between VirG and Atg5. However, Shigella, encoding Type III secretion effector, IcsB,
competitively binds to Atg5, thereby camouflaging its own bacterial target molecule VirG
from autophagic capture [49]. Furthermore, BopA, the counterpart of IcsB in Burkholderia
pseudomallei, have similar autophagy-evading properties [50]. Listeria monocytogenes is a
classic example of a "cytosol-adapted pathogen"; it can rapidly escape from the phagosome
of macrophages and other non-phagocytic cells and replicate rapidly in the cytosol.
Phagosome escape also enables cell-to-cell spread by the bacteria through a bacterial driven
actin-based motility mechanism. Besides Act A, that as was shown plays a critical role in
autophagic escape by polymerizing actin which favors bacteria movements [51], another
virulence factor of L. monocytogenes, InlK, was recently shown to counteract the autophagic
process. InlK interacts with the Major Vault Protein (MVP), the main component of cyto‐
plasmic ribonucleoproteic particules named vaults. The recruitment of MVP to bacterial
surface disguises intracytosolic bacteria from the autophagic recognition system leading to
an increased survival rate [52].
3.3. Autophagy as a survival mechanism
A different type of host-microbial interaction belongs to the group of organisms that harness
cell autophagy. Independently of the final localization within the cell, these particular
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organisms improve their intracellular cycle when interacting with autophagic compartments.
Postulated benefits of host autophagy for microbes include the promotion of viral replication
or morphogenesis via utilization of the autophagic machinery. Polyovirus localized in double-
membrane autophagosome-like structures positive for LC3 serve as lipid membrane-scaffolds
that enhance viral replication [53]. In a similar way, the rotavirus NSP4 protein colocalizes
with LC3-positive vesicular compartments and is postulated to play a role in the formation of
viroplasms and/or the packaging or transcription of the rotavirus genome [54].
Another mechanism is the utilization of autophagosomes as a protective intracellular niche to
enhance the survival and growth of bacteria. As described above, dimorphic bacteria such as
C. burnetii or L. pneumophila follow this method. In contrast, Francisella tularensis, enters LC3-
positive compartments to allow cytoplasmic bacteria to regain access to the endocytic com‐
partment to finally promote bacteria egress through exocytosis [55]. Autophagy could also
favor intracellular pathogen survival by providing nutrients to pathogens, particularly those
that reside in sequestered vacuoles that lack access to cytoplasmic nutrients. That is the case
of T. gondii, which establishes its vacuole in the vicinity of autophagic compartments and that
displays an impaired growth in Atg5-deficient MEF cells, leading to the conclusion that host
cell autophagy plays a role in promoting parasite growth through nutrient recovery [56].
A special type of pathogen-autophagy interaction is produced by the protozoan parasite
Trypanosoma cruzi. This pathogen exploits the autophagic pathway to efficiently colonize host
cells, as will be described in detail in the next section.
3.4. Autophagy as an invasion strategy: The Trypanosoma cruzi case
The protozoan parasite Trypanosoma cruzi can invade a wide range of phagocytic and non-
phagocytic cells in the infective, non-proliferative trypomastigote form. Inside the cell,
trypomastigotes are temporarily contained in a membrane vesicle, the parasitophorous
vacuole. Subsequently, the parasites escape to the cytosol, differentiate into the amastigote
form, and replicate by binary division [57,58]. This replication process culminates after 9 cycles,
followed by a new differentiation period where the parasites undergo a transition back into
trypomastigotes. After that the parasites are released from the cell and infect the neighboring
cells, maintaining the infection process.
The characteristics of the T. cruzi parasitophorous vacuole (TcPV) are directly related to the
parasite invasion mechanism. Previously published data showed that two main invasion
processes involving different signaling pathways are participating: the calcium dependent
fusion of lysosomes with the host plasma membrane [59,60], and the activation of class I
PI3K  that  produces  a  plasma  membrane-derived  vacuole  initially  devoid  of  lysosomal
markers  [61].  Although  both  pathways  require  the  disruption  of  the  host  cell  actin
cytoskeleton, the lysosomal independent T. cruzi entry model appears to be more signifi‐
cant  early  after  internalization  (50%  versus  20%  lysosome-dependent  entry  process).
However, lysosomal fusion is essential for the establishment of a productive infection [62]
and for the progression and completion of the T. cruzi intracellular cycle [63,64], since the
parasite  Tc-Tox is  activated in the acid environment provided by the lysosomes [57,65].
These strategies of cell invasion indicate that T. cruzi entry is a complex process that employs
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different  components  from the  plasma membrane and the  endocytic  pathway to  finally
produce  the  intracellular  infection.  More  recently,  studies  provided  by  our  laboratory
demonstrated  that  the  T.  cruzi  parasitophorous  vacuole  (TcPV)  is  decorated  with  LC3
protein  and  that  the  autophagic  inhibitors  wortmannin,  3-methyladenine  or  vinblastine
suppress this recruitment and also significantly reduce the intracellular infection. In contrast,
induction  of  autophagy  before  infection  by  starvation  or  other  means  significantly  in‐
creased  the  percentage  of  infected  cells.  Interestingly,  infection  was  diminished  in  the
absence of the specific autophagy genes Beclin1 or Atg5, which are required for initiation
of autophagy, indicating that autophagic-derived compartments are required for efficient
entry of T. cruzi  into the host cell  [66].  Live imaging using confocal microscopy showed
that GFP-LC3 positive vesicles move towards plasma membrane and contact the sites where
trypomastigotes, the T. cruzi  invasive forms, bind the membrane [66,67] (Figure 2C). The
pro-pathogen effects of autophagy on T. cruzi infection were observed in different classes
of cells and T. cruzi strains, demonstrating that this interaction is a wide-spread phenomen‐
on [68]. The autophagy modulation of host cells during the following stages of the T. cruzi
intracellular cycle -trypomastigote to amastigote differentiation, amastigote replication and
amastigote  differentiation  back  to  trypomastigote-  seems  to  suffer  no  mdification  com‐
pared to cells maintained in control conditions [66]. Since T. cruzi is an unicellular eukaryotic
organism that also has its  own autophagic pathway [69],  other experimental  procedures
will be necessary to decipher the possible dual action of autophagy modulation on T. cruzi
infected cells. Indeed, unpublished data from our laboratory show that classical inducers
and inhibitors of mammalian autophagy have similar effects on T. cruzi and that protozo‐
an autophagy is activated during T. cruzi metacyclogenesis, a process that renders metacy‐
clic trypomastigotes from epimastigotes and that takes place in the digestive apparatus of
the triatomine vectors.
3.5. Autophagy in action: in vivo infections studies
To date the outcome of the pathogen/autophagy relationship on in vivo infections models, with
the exception of a few cases, remains little understood. Actions of autophagy as an innate
immune component are easier to understand, particularly with the use of knockout mice. In
this way, studies on in vivo M. tuberculosis murine infections showed that the most susceptible
mice are those deficient in either IFN-γ or IFN-γ receptors [70]. These results clearly demon‐
strate that macrophage activation, and the macrophage autophagic pathway [30], are required
as a critical components for controlling infection.
The main concerns with the in vivo models arise from the cases of pathogens that in vitro studies
show to be favored by autophagy induction. At the moment, no current evidence demonstrates
that autophagy gene deletion in the host attenuates microbial disease. Therefore, the physio‐
logical significance of microbial utilization of autophagy for "promicrobial" effects remains to
be established [71]. The discrepant conclusions between in vitro and in vivo studies in T.
gondii infection models exemplify this concept. Although T. gondii has impaired growth in
Atg5-deficient cells, leading to the conclusion that host cell autophagy plays a role in promoting
parasite growth through nutrient recovery [56], this parasite has increased virulence in mice
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with macrophage-specific deletion of Atg5 [72]. In agreement with these results, unpublished
data from our laboratory show that autophagy-impaired mice are more susceptible to T.
cruzi infection, while our previously results on cell cultures clearly demonstrate that decreased
autophagic levels in Atg5 KO cells or in Beclin 1 KD cells significantly decreased T. cruzi
infection [66].
One possible explanation for these discrepancies is the different effects of autophagy (or
autophagic proteins) on phagocytic and non-phagocytic cells. When T. gondii infected macro‐
phages were stimulated with CD40 receptor agonists, the parasite vacuole fuses with endo‐
somes and lysosomes in an autophagy-dependent process leading to parasite destruction
[35,36]. In contrast, in the non-phagocytic HeLa cells, Wang and colleagues reported the
beneficial effects of autophagic induction for parasite survival and growth [56]. Considering
this possibility, the comparative analysis of autophagic modulation on the course of a specific
pathogen infection in phagocytic and non-phagocytic cells in vitro prior to mice infection
would be productive in the future. However, this simplistic point of view will never replace
the conclusions obtained from mice experiments, especially when immune responses are
implicated.
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